ACRP-CP common mistakes
ACRP-CP · Understand the traps and how to avoid them.
Labels a trial's phase by the product type or therapeutic area (for example, calling any oncology study Phase I) instead of by the question the study is designed to answer.
Phase labels are used loosely in workplace conversation, so candidates memorize examples from their own program rather than the defining purpose of each phase: Phase I establishes initial safety, tolerability, and pharmacokinetics; Phase II explores activity and dose; Phase III confirms benefit against a comparator; Phase IV happens after approval.
What to do instead
Build a four-row table with columns for primary question, typical enrollment, control group, and endpoint type. On every practice item, write the study's purpose in one sentence before selecting a phase label.
Treats randomization, blinding, and allocation concealment as interchangeable ways of keeping a trial fair, so any question about bias control gets a generic answer.
The three methods are taught together and all sound like 'keeping the study objective', but they act at different points: allocation concealment prevents foreknowledge of assignment before randomization, randomization balances known and unknown confounders, and blinding limits post-assignment bias in care, assessment, and reporting.
What to do instead
For each term, write one sentence naming when it operates and which bias it controls, then practice distinguishing them in short scenarios rather than definitions alone.
Assumes a participant who signed a consent form at enrollment never needs to be approached again, even after an amendment changes risks, procedures, or visit burden.
Consent is often reduced to a single signature in day-to-day site work. In practice it is an ongoing process, and new information that could affect a person's willingness to continue usually triggers re-consent under IRB/IEC policy, so items about amendments and new risk information are missed.
What to do instead
Before answering, check three things: has new information emerged, could it change the participant's decision, and does the governing IRB/IEC or regulation require a new signature? State which of the three drives your answer.
Uses 'severe' and 'serious' as synonyms, so a severe headache is reported as an SAE while a medically important event is dismissed because it was labeled mild.
Clinicians naturally rank events by intensity, and intensity feels like the important dimension. Regulatory seriousness is a separate outcome-based construct, and expectedness is judged against the reference safety information, not against the reporter's surprise.
What to do instead
Apply the seriousness criteria as a checklist (death, life-threatening, inpatient hospitalization or prolongation, persistent disability, congenital anomaly, important medical event) and rate intensity separately as mild, moderate, or severe.
Answers every regulatory question with the FDA rule even when the scenario is set in Europe or described in ICH terms, or treats an ICH guideline as a law that automatically overrides local regulation.
Most training and workplace habits are built around one jurisdiction. ICH guidance is widely adopted, which creates the impression of a single global rulebook, but binding requirements come from the applicable national or regional authority and can differ in detail.
What to do instead
Tag every regulation you study with its jurisdiction and instrument type. Use ICH as the shared baseline, then note where FDA and EU requirements add to or diverge from it, and check the scenario's location before choosing.
Assigns sponsor duties to the site investigator, or assigns consent and delegation duties to the sponsor, when answering accountability questions.
In daily work the same people interact across organizations and tasks get done collaboratively, so the boundary between who performs a task and who is accountable for it blurs. Exam items test accountability, not who happened to help.
What to do instead
Draw a three-column table for each major activity (sponsor, investigator, IRB/IEC) and fill in who is accountable, including trial initiation, monitoring, investigational product supply, consent, delegation, and safety reporting. Name the accountable party before selecting an option.
Signs off on a delegation log entry after the coordinator has already performed the task, or lists a task for a staff member whose training record does not cover it.
Sites are busy and documentation often catches up with practice. Delegation feels administrative, so candidates approve it retroactively or assume qualifications from job title rather than from documented training and licensure.
What to do instead
Check three things before signing: the task was delegated before it was performed, the person's qualifications and training are documented, and the investigator has a documented oversight mechanism. Apply the same three checks to scenario questions.
Treats the EDC entry as the source record when no certified copy exists, or resolves a query by changing the database without correcting the source and recording why.
Electronic systems look authoritative and are easy to edit, so the distinction between source and transcribed data erodes. Candidates also treat query resolution as a data-cleaning task rather than a documented reconciliation of source and database.
What to do instead
For any data question, identify the source first, then test the record against ALCOA+ (attributable, legible, contemporaneous, original, accurate, complete, consistent, enduring, available), and confirm corrections preserve the original with an audit trail and a stated reason.
When a scenario describes a site problem, selects the most forceful option, such as escalating to the sponsor immediately or removing a coordinator, rather than the option that matches the leader's accountability and the protocol's escalation path.
Candidates associate participant safety with dramatic action and over-correct toward visible intervention. Scenario items reward proportionate judgment: protect participants first, then follow the defined chain and document, without inventing steps the protocol does not require.
What to do instead
Use a fixed sequence: is anyone at immediate risk, what does the protocol or SOP require, who must be told and by when, and what prevents recurrence? Choose the option that satisfies all four and reject options that skip a step or add an unauthorized one.
Chooses an answer that assigns blame or avoids direct contact, such as emailing a complaint about a coordinator to the sponsor without first speaking with the site team, instead of an option that closes the communication loop.
Under exam pressure, the most formal-sounding option looks safest, and confrontation feels risky. Teamwork items actually test whether the message is received, understood, and acted on by a named person within a stated timeframe, with a record kept.
What to do instead
Look for the option containing a read-back or confirmation of understanding, a named responsible person, a timeframe, and documentation. Reject options that skip direct communication, rely on assumptions, or leave ownership unclear.